Azacitidine-induced acute lung injury in a patient with therapy-related myelodysplastic syndrome

Azacitidine is a first-in-class demethylating agent, and it is widely used globally as a first-line treatment for higher-risk myelodysplastic syndrome (MDS). Here, we report the case of a patient with MDS who suffered from a rare adverse event, an acute lung injury (ALI), which was suspected to have...

Descripción completa

Detalles Bibliográficos
Autores principales: Makita, Shinichi, Munakata, Wataru, Watabe, Daisuke, Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Toyoda, Kosuke, Yamauchi, Nobuhiko, Fukuhara, Suguru, Maruyama, Dai, Kobayashi, Yukio, Tobinai, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536648/
https://www.ncbi.nlm.nih.gov/pubmed/28415946
http://dx.doi.org/10.1177/0300060517698331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536648/
https://www.ncbi.nlm.nih.gov/pubmed/28415946
http://dx.doi.org/10.1177/0300060517698331

Ejemplares similares